How do you treat muscle-invasive and metastatic sarcomatoid bladder cancer?
Is there a role for neoadjuvant cisplatin-based chemotherapy?
Do patients with sarcomatoid histology respond to checkpoint inhibitors?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Washington School of Medicine
Answered on
This is a very challenging disease with poor prognosis and low response rate to therapy. If it's predominant or pure sarcomatoid, we are opening a neoadjuvant clinical trial with dose dense MVAC plus pembrolizumab before surgery. If there is no trial, I would do upfront radical cystectomy and PLND for localized disease. If it's metastatic disease, I would start with chemotherapy (dose dense MVAC or Gemzar/Cisplatin in fit patients for Urothelial mixed), or a sarcoma regimen for pure sarcomatoid.
Join for free or sign in to see the full answer